Table 1.
Variable | Definition |
---|---|
Temperature | |
Body | Abdominal skin temp in oC |
Hypothermia | Body temp < 36.5oC |
Hyperthermia | Body temp > 37.2oC |
Euthermia | Body temp 36.5oC to 37.2oC |
Hypothermic episode | Begins when body temp < 36.5oC & ends when body temp ≥ 36.5oC (in min) |
Hyperthermic episode | Begins when body temp < 37.2oC & ends when body temp ≥ 37.2oC (in min) |
Acute Respiratory Morbidity | |
Desaturation | SpO2 < 90% |
Brady/Desaturation | Heart rate < 100 & SpO2 < 90% |
Apnea | Time of apnea plus 15 min prior & 5 min after |
FiO2 increase | Time of FiO2 increase plus 15 min prior to & 5 min after |
RS increase | Time of PIP, PEEP, or RR increase plus 15 min prior to & 5 min after |
Chronic Respiratory Morbidity | |
CRMR | Diagnosis of BPD or SD |
BPD | FiO2 > 21% at 28 DOL or 36 weeks PMA |
SD | No diagnosis of BPD, but receiving scheduled diuretic dosing for respiratory symptoms at 36 weeks PMA |
Covariates | |
Chorioamnionitis | Maternal diagnosis of chorioamnionitis |
GA | Gestational age at birth in weeks |
Birthweight | Birthweight in grams |
SGA | Birthweight < 10th percentile on growth curve |
Sex | Female or Male |
Apgar Scores | Apgar score at 1 & 5 minutes |
Surfactant | Received at least one dose of surfactant |
Infection | Sepsis or presumed sepsis during the first 14 DOL |
temp temperature; FiO2 fraction of inspired air; SpO2 peripheral capillary oxygen saturation; min minute; RS respiratory support; BPD bronchopulmonary dysplasia; SD scheduled diuretics dosing; CRMR chronic respirtory morbidity risk; DOL days of life; PMA postmenstrual age; GA gestational age; SGA small for gestational age; IUGR intrauterine growth restriction